July 8, 2015 - Sorin S.p.A. and Cyberonics Inc. unveiled LivaNova as the name of their combined company, effective at the close of their proposed merger.
The name was chosen through a comprehensive market research process, including participation by employees of both companies worldwide, which produced several thousand proposed names. LivaNova embodies the spirit that will infuse the new company and evokes the essence of what makes the combination unique.
LivaNova will operate as three business units: Cardiac Surgery, Cardiac Rhythm Management and Neuromodulation, with operating headquarters in Mirandola (Italy), Clamart (France) and Houston (U.S.), respectively. The company will have a presence in more than 100 countries around the world with approximately 4,500 employees.
Until the closing of the transaction, both companies will continue to operate separately under their current brand names and leadership structures. As previously announced, the transaction is expected to be completed by the end of the third calendar quarter of 2015 and is subject to approval by Cyberonics' stockholders, the receipt of required regulatory clearances, and other customary closing conditions.
The cross-border merger of Sorin with and into Livanova plc (formerly called Sand Holdco PLC) was approved by Sorin's shareholders at its extraordinary shareholders' meeting held on May 26, 2015.
For more information: www.sorin.com, www.cyberonics.com
March 23, 2026 
